BRCA1 and BRCA2 Mutation Predictions in French-Canadian Families
Author Information
Author(s): Antoniou Antonis, Durocher Francine, Smith Paula, Simard Jacques, Easton Douglas F
Primary Institution: Cancer Research UK Genetic Epidemiology Unit, University of Cambridge
Hypothesis
The study evaluates the accuracy of the BRCAPRO and BOADICEA models in predicting BRCA1 and BRCA2 mutations in high-risk French-Canadian families.
Conclusion
The BOADICEA model accurately predicts carrier probabilities in French-Canadian families and is suitable for counseling in this population.
Supporting Evidence
- The BOADICEA model predicted accurately the number of BRCA1 and BRCA2 mutations.
- BRCAPRO over-predicted the number of mutations in almost all groups of families.
- The estimated risks for breast and ovarian cancer in mutation carriers were consistent with previously published estimates.
Takeaway
This study looked at families with breast cancer to see how well two models can guess if someone has a gene that increases cancer risk. One model did a really good job!
Methodology
The study recruited 195 families with breast or ovarian cancer and compared observed mutation statuses with predictions from the BOADICEA and BRCAPRO models.
Potential Biases
Potential bias due to the selection of families based on cancer history.
Limitations
The estimates are associated with large confidence intervals due to the small number of mutation-positive families considered.
Participant Demographics
High-risk French-Canadian families, primarily descendants of early French immigrants.
Statistical Information
P-Value
6 × 10^-6
Confidence Interval
95% CI 0–93%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website